Cost is only one aspect of accessmany urban consumers already spend comparable amounts on discretionary expenses given any weekend
GLP-1, short for glucagon-like-peptide-1, is, in the simplest terms, a hormone our intestines naturally make after a meal that regulates blood sugar and signals fullness to the brain, as explained by Dr
Common and Serious Side Effects The most frequent issues include nausea, vomiting, constipation, and diarrhea
The label was updated with clinical trials data that supporting its effectiveness and safety for the longer period of use
Dosing in the Phase 3 Diabetes Trial (TRANSCEND-T2D-1) A1C reduction: -1.7% to -2.0% across doses (from baseline 7-9.5%) Weight loss at 12 mg: 16.8% (-36.6 lbs) at 40 weeks Discontinuation due to adverse events was relatively low across all doses, similar to the patterns seen in TRIUMPH-4 The diabetes population typically loses less weight on GLP-1 drugs than the obesity-only population, which is consistent with what was observed: ~17% weight loss in T2D vs
